By Dave Sebastian

 

Moderna Inc. said it has tapped Paul Burton, a Johnson & Johnson executive, as its chief medical officer, effective July 6.

Dr. Burton served as chief global medical affairs officer of Janssen Pharmaceuticals from March 2020 and spent 16 years with J&J. He would succeed Tal Zaks, who is leaving Moderna after six years of service.

Dr. Burton's entry in the company comes as the company is seeking authorization from various governments' health regulators to authorize the use of its Covid-19 shot in adolescents. Chief Executive Stephane Bancel said results of testing Moderna's vaccine in children as young as five years could become available by the fall, which if positive could lead to regulatory authorization of its use in the younger age group.

 

Write to Dave Sebastian at dave.sebastian@wsj.com

 

(END) Dow Jones Newswires

June 14, 2021 08:35 ET (12:35 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Johnson and Johnson Charts.